Systematic Review of Safety of MF59-Adjuvanted Influenza Vaccine in Older Adults
: MF59-adjuvanted influenza vaccines have a favorable and well-characterized safety profile in adults aged 60 years and older. Adverse events are predominantly mild and transient, with no evidence of increased risk of serious or immune-mediated outcomes compared with non-adjuvanted vaccines.
Authors
- M Manzotti (ORCID: https://orcid.org/0000-0002-8934-7013)
- A Bengolea (ORCID: https://orcid.org/0000-0001-5741-5221)
- Hebe Vazquez (ORCID: https://orcid.org/0009-0003-7728-9543)
Institutions
- Hospital Británico de Buenos Aires (AR)
- Favaloro Foundation (AR)
Publication Details
- Journal
- Vaccines
- Published
- 2026-04-17
- DOI
- https://doi.org/10.3390/vaccines14040360
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Seqirus